NeuroDex is developing a suite of blood-based biomarkers based on isolation of cell-specific extracellular vesicles (exosomes)

A drug discovery company that is targeting undetected microscopic metastatic tumors.

ABI LAB is an affordable 85,000 square-feet Boston-based Accelerator and Bio-Incubator whose mission is to support start-up companies, and to accelerate their drug discovery programs, through the availability of 60 state-of-the art lab spaces and innovative pre-clinical services through its strategic partner - SBH Sciences - The world leader in cytokine production, cell-based assays, and biomarker analysis that already provided its services to over 300 biotechnology companies.ABI-LAB is currently providing lab space to 45 biotechnology and diagnostics companies. We collaborate with entrepreneurs throughout their journey, to resolve unmet medical needs. https://abi-lab.com

SBH Sciences is a MA-based biotechnology company engaged in three discovery programs for small and large molecules. To finance our activity, we are providing comprehensive preclinical process development services to the biopharmaceutical, diagnostics and biotechnology industries including cell culture (mammalian and insect cell), customized protein purification, cell-based assays including in-vitro lead drug optimization, cytokines bioassays, ELISA Development, automatic Western Blot and Multiplex Analysis.Our array of cytokine bioassay services is the most comprehensive in the US and includes over 300 bioassays that can accelerate discovery and biopharma development programs. Moreover, our proprietary processes have achieved commercial production of thirty four monoclonal antibodies and thirty one highly purified recombinant cytokines, currently sold to the scientific community worldwide. A few of our most popular products include: Activin A, BMP-7, BMP-2, HGF, human and murine Interleukin 12 (IL-12) and Interleukin 23 (IL-23). We are also offering 8 recombinant glycosyltransferase enzymes.www.sbhsciences.com

SBH Diagnostics is an innovative Contract Research Organization (CRO) and CLIA Lab dedicated to providing accurate and reproducible biomarker analysis services. We are focused on the commercialization of Laboratory Developed Tests (LDTs). In the SBH Diagnostics portfolio under CLIA auspices are the Pico-molar C-Peptide test, the High-specific Glucagon Test and and the EASy-Sjogren's test using the Automatic Simple Western process.The SBH Diagnostics Service offers Simple Western currently used in large pharmaceuticals for vaccine development, cell lysate analysis (from tissue culture or tumors), identification and quantitation of tumor-associated proteins, focusing on key kinase inhibitor targets in precious clinical patient samples. Proteins can be separated by size as in traditional PAGE Western or by their pI as in traditional capillary electrophoresis . SBH Diagnostics is located in Natick, MA.

Alma Bio Therapeutics, a Lyon-based start-up company commercializing Weizmann Institute discoveries, brings forward a "Post Biologics" Generation of curative immune-modulator drugs that reboot the dysregulated immune system using the body's own "Restart" signals. Alma Bio Therapeutics is targeting Inflammatory Bowel Disease (IBD), a chronic incurable autoimmune disease.

Sky Ventures is a MA-based investment group that provides seed funding to early-stage life science and healthcare companies. SBH Sciences is a sponsor of Sky Ventures since inception and provides to start ups biotechnology companies with Lab space and a full range of lab services and propel innovation and economic growth.